Login / Signup
Reading Ashton
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 1
Top Topics
Regulatory T Cells
Early Stage
Anti Inflammatory
Epithelial Mesenchymal Transition
Top Venues
Molecular cancer therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Hong Wang
,
Vinayak Khattar
,
Jonathan A Hensel
,
Reading Ashton
,
Yun Lu
,
Anna G Sorace
,
Yong Wang
,
Jessy S Deshane
,
Joshua L Mieher
,
Champion C S Deivanayagam
,
Selvarangan Ponnazhagan
Systemic Checkpoint Blockade by PD-L1 Single-Chain Antibody Confers Potent Antitumor Immunity and Long-term Survival.
Molecular cancer therapeutics
21 (11) (2022)